YAEL SCHREIBER: Open Payments
NPI 1629375381 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$317 in 10 payments from 9 companies in 2025. Trend: 2023 $273 · 2024 $335 · 2025 $317
Food & beverage: $317
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 1 | $107 |
| HARMONY BIOSCIENCES LLC | 2 | $61 |
| Neurocrine BioSciences, Inc. | 1 | $32 |
| ABBVIE INC. | 1 | $26 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| TMS NeuroHealth Centers Inc. | 1 | $17 |
| Lundbeck LLC | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
Products named: ZURZUVAE, WAKIX, INGREZZA, VRAYLAR, AUSTEDO XR, TMS NeuroHealth Centers Inc., REXULTI, TRINTELLIX.
Industry payments across MD — which companies pay providers there.
